The Infectious Diseases Society of America (IDSA) recently updated guidance for the treatment of antimicrobial-resistant gram-negative infections (bit.ly/3WJoscE-idse).
The guidance updated recommendations for treating infections caused by extended-spectrum beta-lactamase–producing Enterobacterales (ESBL-E), AmpC beta-lactamase–producing Enterobacterales, carbapenem-resistant Enterobacterales (CRE), Pseudomonas aeruginosa with difficult-to-treat resistance (DTR), carbapenem-resistant